Click here to get full coverage on Biogen (BIIB) Stock Trades Up, Here Is Why - FinancialContent

Biogen (BIIB) Stock Trades Up, Here Is Why  FinancialContent

Biogen (BIIB) Stock Trades Up, Here Is Why - FinancialContent

Click here to get full coverage on HSBC Downgrades Biogen Inc. (BIIB) to Reduce Despite Pipeline Progress - Yahoo Finance

HSBC Downgrades Biogen Inc. (BIIB) to Reduce Despite Pipeline Progress  Yahoo Finance

HSBC Downgrades Biogen Inc. (BIIB) to Reduce Despite Pipeline Progress - Yahoo Finance

Click here to get full coverage on Biogen (NASDAQ:BIIB) Price Target Raised to $165.00 - MarketBeat

Biogen (NASDAQ:BIIB) Price Target Raised to $165.00  MarketBeat

Biogen (NASDAQ:BIIB) Price Target Raised to $165.00 - MarketBeat

Click here to get full coverage on Biogen (BIIB) Set to Advance New Drug BIIB145 from Collaboration - GuruFocus

Biogen (BIIB) Set to Advance New Drug BIIB145 from Collaboration  GuruFocus

Biogen (BIIB) Set to Advance New Drug BIIB145 from Collaboration - GuruFocus

Click here to get full coverage on Biogen (BIIB) Valuation Check After Positive Neurology Data for Lecanemab and Zorevunersen - Sahm

Biogen (BIIB) Valuation Check After Positive Neurology Data for Lecanemab and Zorevunersen  Sahm

Biogen (BIIB) Valuation Check After Positive Neurology Data for Lecanemab and Zorevunersen - Sahm

Click here to get full coverage on Biogen (BIIB): Reassessing Valuation After a Recent 3-Month Share Price Rebound - Yahoo Finance

Biogen (BIIB): Reassessing Valuation After a Recent 3-Month Share Price Rebound  Yahoo Finance

Biogen (BIIB): Reassessing Valuation After a Recent 3-Month Share Price Rebound - Yahoo Finance

Click here to get full coverage on Biogen (BIIB) Valuation Check After Positive Neurology Data for Lecanemab and Zorevunersen - simplywall.st

Biogen (BIIB) Valuation Check After Positive Neurology Data for Lecanemab and Zorevunersen  simplywall.st

Biogen (BIIB) Valuation Check After Positive Neurology Data for Lecanemab and Zorevunersen - simplywall.st

Click here to get full coverage on Biogen: Alzheimer's Disease Treatment Needs More Real-World Data (NASDAQ:BIIB) - Seeking Alpha

Biogen: Alzheimer's Disease Treatment Needs More Real-World Data (NASDAQ:BIIB)  Seeking Alpha

Biogen: Alzheimer's Disease Treatment Needs More Real-World Data (NASDAQ:BIIB) - Seeking Alpha

Click here to get full coverage on Amazon’s ‘Handy’ Multitool Pen Is Now Only $8 — And It Makes a Great Stocking Stuffer - Autoblog

Amazon’s ‘Handy’ Multitool Pen Is Now Only $8 — And It Makes a Great Stocking Stuffer  Autoblog

Amazon’s ‘Handy’ Multitool Pen Is Now Only $8 — And It Makes a Great Stocking Stuffer - Autoblog

Click here to get full coverage on Pitcairn Co. Acquires Shares of 7,454 Biogen Inc. $BIIB - MarketBeat

Pitcairn Co. Acquires Shares of 7,454 Biogen Inc. $BIIB  MarketBeat

Pitcairn Co. Acquires Shares of 7,454 Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Is Biogen a Mispriced Opportunity After Renewed Interest in Its Neurology Pipeline? - simplywall.st

Is Biogen a Mispriced Opportunity After Renewed Interest in Its Neurology Pipeline?  simplywall.st

Is Biogen a Mispriced Opportunity After Renewed Interest in Its Neurology Pipeline? - simplywall.st

Click here to get full coverage on Hudson Bay Capital Management LP Buys 67,220 Shares of Biogen Inc. $BIIB - MarketBeat

Hudson Bay Capital Management LP Buys 67,220 Shares of Biogen Inc. $BIIB  MarketBeat

Hudson Bay Capital Management LP Buys 67,220 Shares of Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Biogen Inc. (NASDAQ:BIIB) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Biogen Inc. (NASDAQ:BIIB) Receives Average Recommendation of "Hold" from Brokerages  MarketBeat

Biogen Inc. (NASDAQ:BIIB) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Click here to get full coverage on A Look at Biogen (BIIB) Valuation Following New Dravet Syndrome Study Results - Yahoo Finance

A Look at Biogen (BIIB) Valuation Following New Dravet Syndrome Study Results  Yahoo Finance

A Look at Biogen (BIIB) Valuation Following New Dravet Syndrome Study Results - Yahoo Finance

Click here to get full coverage on Biogen Inc. (BIIB): A Bull Case Theory - Yahoo Finance

Biogen Inc. (BIIB): A Bull Case Theory  Yahoo Finance

Biogen Inc. (BIIB): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?  Yahoo Finance

Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

Click here to get full coverage on Jefferies Initiates Coverage on Biogen Inc. (BIIB) with Buy Rating and $190 PT - Yahoo Finance

Jefferies Initiates Coverage on Biogen Inc. (BIIB) with Buy Rating and $190 PT  Yahoo Finance

Jefferies Initiates Coverage on Biogen Inc. (BIIB) with Buy Rating and $190 PT - Yahoo Finance

Click here to get full coverage on Biogen Inc. (NASDAQ:BIIB) Doing What It Can To Lift Shares - 富途牛牛

Biogen Inc. (NASDAQ:BIIB) Doing What It Can To Lift Shares  富途牛牛

Biogen Inc. (NASDAQ:BIIB) Doing What It Can To Lift Shares - 富途牛牛

Click here to get full coverage on Wells Fargo Maintains Biogen (BIIB) Equal-Weight Recommendation - Nasdaq

Wells Fargo Maintains Biogen (BIIB) Equal-Weight Recommendation  Nasdaq

Wells Fargo Maintains Biogen (BIIB) Equal-Weight Recommendation - Nasdaq

Click here to get full coverage on Is New Neurology Data And Partnerships Altering The Investment Case For Biogen (BIIB)? - Yahoo Finance

Is New Neurology Data And Partnerships Altering The Investment Case For Biogen (BIIB)?  Yahoo Finance

Is New Neurology Data And Partnerships Altering The Investment Case For Biogen (BIIB)? - Yahoo Finance

Click here to get full coverage on H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects - Yahoo Finance

H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects  Yahoo Finance

H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects - Yahoo Finance

Click here to get full coverage on BIIB Stock: Is Biogen Still A Buy After The 14% Spike? - Forbes

BIIB Stock: Is Biogen Still A Buy After The 14% Spike?  Forbes

BIIB Stock: Is Biogen Still A Buy After The 14% Spike? - Forbes

Click here to get full coverage on Stifel Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $202 - 富途牛牛

Stifel Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $202  富途牛牛

Stifel Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $202 - 富途牛牛

Click here to get full coverage on How BIIB stock responds to policy changes - Earnings Recap Report & Free Real-Time Volume Trigger Notifications - DonanımHaber

How BIIB stock responds to policy changes - Earnings Recap Report & Free Real-Time Volume Trigger Notifications  DonanımHaber

How BIIB stock responds to policy changes - Earnings Recap Report & Free Real-Time Volume Trigger Notifications - DonanımHaber

Click here to get full coverage on 1 Nasdaq 100 Stock Worth Your Attention and 2 Facing Headwinds - The Globe and Mail

1 Nasdaq 100 Stock Worth Your Attention and 2 Facing Headwinds  The Globe and Mail

1 Nasdaq 100 Stock Worth Your Attention and 2 Facing Headwinds - The Globe and Mail

Click here to get full coverage on Biogen Inc. (BIIB) Q3 Earnings and Revenues Top Estimates - Nasdaq

Biogen Inc. (BIIB) Q3 Earnings and Revenues Top Estimates  Nasdaq

Biogen Inc. (BIIB) Q3 Earnings and Revenues Top Estimates - Nasdaq

Click here to get full coverage on Firing on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the Way - Yahoo Finance

Firing on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the Way  Yahoo Finance

Firing on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the Way - Yahoo Finance

Click here to get full coverage on Biogen Inc. $BIIB Shares Purchased by Balyasny Asset Management L.P. - MarketBeat

Biogen Inc. $BIIB Shares Purchased by Balyasny Asset Management L.P.  MarketBeat

Biogen Inc. $BIIB Shares Purchased by Balyasny Asset Management L.P. - MarketBeat

Click here to get full coverage on New Analyst Forecast: $BIIB Given $143 Price Target - Quiver Quantitative

New Analyst Forecast: $BIIB Given $143 Price Target  Quiver Quantitative

New Analyst Forecast: $BIIB Given $143 Price Target - Quiver Quantitative

Click here to get full coverage on Biogen Inc. (BIIB)’s Alzheimer’s Drug Leqembi Wins EU Nod, Now Approved in 48 Countries - Yahoo Finance

Biogen Inc. (BIIB)’s Alzheimer’s Drug Leqembi Wins EU Nod, Now Approved in 48 Countries  Yahoo Finance

Biogen Inc. (BIIB)’s Alzheimer’s Drug Leqembi Wins EU Nod, Now Approved in 48 Countries - Yahoo Finance

Click here to get full coverage on Fund Update: 282,084 BIOGEN (BIIB) shares added to Zurcher Kantonalbank (Zurich Cantonalbank) portfolio - Quiver Quantitative

Fund Update: 282,084 BIOGEN (BIIB) shares added to Zurcher Kantonalbank (Zurich Cantonalbank) portfolio  Quiver Quantitative

Fund Update: 282,084 BIOGEN (BIIB) shares added to Zurcher Kantonalbank (Zurich Cantonalbank) portfolio - Quiver Quantitative

Click here to get full coverage on Should Biogen’s (BIIB) Surging New Drug Sales Reshape Investors’ Expectations for Future Growth? - Yahoo Finance

Should Biogen’s (BIIB) Surging New Drug Sales Reshape Investors’ Expectations for Future Growth?  Yahoo Finance

Should Biogen’s (BIIB) Surging New Drug Sales Reshape Investors’ Expectations for Future Growth? - Yahoo Finance

Click here to get full coverage on BIIB Q2 Deep Dive: New Launches Offset Legacy Pressure, Pipeline Advancements Drive Guidance - Yahoo Finance

BIIB Q2 Deep Dive: New Launches Offset Legacy Pressure, Pipeline Advancements Drive Guidance  Yahoo Finance

BIIB Q2 Deep Dive: New Launches Offset Legacy Pressure, Pipeline Advancements Drive Guidance - Yahoo Finance

Click here to get full coverage on Axa S.A. Sells 45,397 Shares of Biogen Inc. $BIIB - MarketBeat

Axa S.A. Sells 45,397 Shares of Biogen Inc. $BIIB  MarketBeat

Axa S.A. Sells 45,397 Shares of Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Biogen (BIIB) Is Down 5.2% After HSBC Downgrade Amid Mixed Drug Pipeline Signals – Has The Bull Case Changed? - Sahm

Biogen (BIIB) Is Down 5.2% After HSBC Downgrade Amid Mixed Drug Pipeline Signals – Has The Bull Case Changed?  Sahm

Biogen (BIIB) Is Down 5.2% After HSBC Downgrade Amid Mixed Drug Pipeline Signals – Has The Bull Case Changed? - Sahm

Click here to get full coverage on Biogen Inc. (BIIB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Biogen Inc. (BIIB) Stock Price | Live Quotes & Charts | NASDAQ  StocksToTrade

Biogen Inc. (BIIB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Click here to get full coverage on Biogen (BIIB): One-Time $471M Loss Raises Fresh Doubts Over Rebounding Profit Narrative - Yahoo Finance

Biogen (BIIB): One-Time $471M Loss Raises Fresh Doubts Over Rebounding Profit Narrative  Yahoo Finance

Biogen (BIIB): One-Time $471M Loss Raises Fresh Doubts Over Rebounding Profit Narrative - Yahoo Finance

Click here to get full coverage on Hudson Bay Capital Management LP Has $33.63 Million Position in Biogen Inc. $BIIB - MarketBeat

Hudson Bay Capital Management LP Has $33.63 Million Position in Biogen Inc. $BIIB  MarketBeat

Hudson Bay Capital Management LP Has $33.63 Million Position in Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Biogen (BIIB): Assessing Valuation After Promising New Zorevunersen Data in Dravet Syndrome - Sahm

Biogen (BIIB): Assessing Valuation After Promising New Zorevunersen Data in Dravet Syndrome  Sahm

Biogen (BIIB): Assessing Valuation After Promising New Zorevunersen Data in Dravet Syndrome - Sahm

Click here to get full coverage on Biogen (BIIB) Stock Trades Down, Here Is Why - Yahoo Finance

Biogen (BIIB) Stock Trades Down, Here Is Why  Yahoo Finance

Biogen (BIIB) Stock Trades Down, Here Is Why - Yahoo Finance

Click here to get full coverage on State Street Corp Raises Position in Biogen Inc. $BIIB - MarketBeat

State Street Corp Raises Position in Biogen Inc. $BIIB  MarketBeat

State Street Corp Raises Position in Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Biogen to Report Third Quarter 2025 Financial Results October 30, 2025 - Biogen

Biogen to Report Third Quarter 2025 Financial Results October 30, 2025  Biogen

Biogen to Report Third Quarter 2025 Financial Results October 30, 2025 - Biogen

Click here to get full coverage on LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" - PR Newswire

LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"  PR Newswire

LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" - PR Newswire

Click here to get full coverage on BIIB January 2026 Options Begin Trading - Nasdaq

BIIB January 2026 Options Begin Trading  Nasdaq

BIIB January 2026 Options Begin Trading - Nasdaq

Click here to get full coverage on Canaccord Genuity Reiterates a Buy on Biogen (BIIB) - Yahoo Finance

Canaccord Genuity Reiterates a Buy on Biogen (BIIB)  Yahoo Finance

Canaccord Genuity Reiterates a Buy on Biogen (BIIB) - Yahoo Finance

Click here to get full coverage on 3 Reasons BIIB is Risky and 1 Stock to Buy Instead - Yahoo Finance

3 Reasons BIIB is Risky and 1 Stock to Buy Instead  Yahoo Finance

3 Reasons BIIB is Risky and 1 Stock to Buy Instead - Yahoo Finance

Click here to get full coverage on Biogen (BIIB) Valuation: Exploring the Discount as Investor Sentiment Shifts - Yahoo Finance

Biogen (BIIB) Valuation: Exploring the Discount as Investor Sentiment Shifts  Yahoo Finance

Biogen (BIIB) Valuation: Exploring the Discount as Investor Sentiment Shifts - Yahoo Finance

Click here to get full coverage on 3 Mid-Cap Stocks We Find Risky - The Globe and Mail

3 Mid-Cap Stocks We Find Risky  The Globe and Mail

3 Mid-Cap Stocks We Find Risky - The Globe and Mail

Click here to get full coverage on Biogen (NASDAQ:BIIB) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat

Biogen (NASDAQ:BIIB) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says  MarketBeat

Biogen (NASDAQ:BIIB) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat

Click here to get full coverage on BIIB Beats on Q3 Earnings & Sales, Stock Down on Lowered '25 EPS View - October 30, 2025 - Zacks Investment Research

BIIB Beats on Q3 Earnings & Sales, Stock Down on Lowered '25 EPS View - October 30, 2025  Zacks Investment Research

BIIB Beats on Q3 Earnings & Sales, Stock Down on Lowered '25 EPS View - October 30, 2025 - Zacks Investment Research

Click here to get full coverage on Biogen Inc (NASDAQ:BIIB) Nasdaq Composite ETF Neuro Innovation - Kalkine Media

Biogen Inc (NASDAQ:BIIB) Nasdaq Composite ETF Neuro Innovation  Kalkine Media

Biogen Inc (NASDAQ:BIIB) Nasdaq Composite ETF Neuro Innovation - Kalkine Media

Click here to get full coverage on Biogen Inc. $BIIB Stake Reduced by Schroder Investment Management Group - MarketBeat

Biogen Inc. $BIIB Stake Reduced by Schroder Investment Management Group  MarketBeat

Biogen Inc. $BIIB Stake Reduced by Schroder Investment Management Group - MarketBeat

Click here to get full coverage on Biogen (Nasdaq: BIIB), Dayra to Develop Oral Macrocyclic Peptides for Immunology - Stock Titan

Biogen (Nasdaq: BIIB), Dayra to Develop Oral Macrocyclic Peptides for Immunology  Stock Titan

Biogen (Nasdaq: BIIB), Dayra to Develop Oral Macrocyclic Peptides for Immunology - Stock Titan

Click here to get full coverage on Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates  Yahoo Finance

Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Click here to get full coverage on Biogen Inc. $BIIB Shares Bought by Guggenheim Capital LLC - MarketBeat

Biogen Inc. $BIIB Shares Bought by Guggenheim Capital LLC  MarketBeat

Biogen Inc. $BIIB Shares Bought by Guggenheim Capital LLC - MarketBeat

Click here to get full coverage on AbbVie upgraded, Biogen downgraded as HSBC reflects on 2026 in pharma - Seeking Alpha

AbbVie upgraded, Biogen downgraded as HSBC reflects on 2026 in pharma  Seeking Alpha

AbbVie upgraded, Biogen downgraded as HSBC reflects on 2026 in pharma - Seeking Alpha

Click here to get full coverage on Lido Advisors LLC Has $647,000 Stock Holdings in Biogen Inc. $BIIB - MarketBeat

Lido Advisors LLC Has $647,000 Stock Holdings in Biogen Inc. $BIIB  MarketBeat

Lido Advisors LLC Has $647,000 Stock Holdings in Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Biogen (BIIB) Sees Target Price Increase by Morgan Stanley | BII - GuruFocus

Biogen (BIIB) Sees Target Price Increase by Morgan Stanley | BII  GuruFocus

Biogen (BIIB) Sees Target Price Increase by Morgan Stanley | BII - GuruFocus

Click here to get full coverage on Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for  Yahoo Finance

Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Click here to get full coverage on American Century Companies Inc. Increases Stock Holdings in Biogen Inc. $BIIB - MarketBeat

American Century Companies Inc. Increases Stock Holdings in Biogen Inc. $BIIB  MarketBeat

American Century Companies Inc. Increases Stock Holdings in Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Biogen (BIIB) Reports Earnings Tomorrow: What To Expect - Yahoo Finance

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect  Yahoo Finance

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect - Yahoo Finance

Click here to get full coverage on BIIB's sNDA for Higher Dose of SMA Drug Spinraza Gets FDA's CRL - Yahoo Finance

BIIB's sNDA for Higher Dose of SMA Drug Spinraza Gets FDA's CRL  Yahoo Finance

BIIB's sNDA for Higher Dose of SMA Drug Spinraza Gets FDA's CRL - Yahoo Finance

Click here to get full coverage on Federated Hermes Inc. Acquires 17,069 Shares of Biogen Inc. $BIIB - MarketBeat

Federated Hermes Inc. Acquires 17,069 Shares of Biogen Inc. $BIIB  MarketBeat

Federated Hermes Inc. Acquires 17,069 Shares of Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Bernstein Maintains Biogen (BIIB) Market Perform Recommendation - Nasdaq

Bernstein Maintains Biogen (BIIB) Market Perform Recommendation  Nasdaq

Bernstein Maintains Biogen (BIIB) Market Perform Recommendation - Nasdaq

Click here to get full coverage on Wells Fargo Sticks to Its Hold Rating for Biogen (BIIB) - The Globe and Mail

Wells Fargo Sticks to Its Hold Rating for Biogen (BIIB)  The Globe and Mail

Wells Fargo Sticks to Its Hold Rating for Biogen (BIIB) - The Globe and Mail

Click here to get full coverage on California Public Employees Retirement System Sells 46,044 Shares of Biogen Inc. $BIIB - MarketBeat

California Public Employees Retirement System Sells 46,044 Shares of Biogen Inc. $BIIB  MarketBeat

California Public Employees Retirement System Sells 46,044 Shares of Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Amundi Cuts Position in Biogen Inc. $BIIB - MarketBeat

Amundi Cuts Position in Biogen Inc. $BIIB  MarketBeat

BIIB

Price Chart

Key Statistics

Technicals

About BIIB

Latest News

Biogen (BIIB) Stock Trades Up, Here Is Why - FinancialContent

HSBC Downgrades Biogen Inc. (BIIB) to Reduce Despite Pipeline Progress - Yahoo Finance

Biogen (NASDAQ:BIIB) Price Target Raised to $165.00 - MarketBeat

Advanced Charts

Top Gainers

Top Losers